Erkek alkol bağımlılarında depreşme ile ilişkili etkenler: 12 aylık takip çalışması

Amaç: Bu çalışmanın amacı, erkek alkol bağımlılarında yatarak tedavinin ardından, 12 aylık takipte alkol kullanımının depreşmesiyle ilişkili klinik değişkenlerin saptanmasıdır. Yöntem: Çalışmaya, ardışık olarak hastaneye yatırılmış 156 erkek alkol bağımlısı hasta katılmıştır. Yatarak tedaviden 12 ay sonra, bu hastalardan 102’sinin değerlendirilmesi mümkün olmuştur. Hastalar, başlangıçta, Belirti Tarama Listesi (SCL-90) ve Michigan Alkolizm Tarama Testi (MATT), 12 ay sonra ise PENN Alkol Aşerme Ölçeği (PAAÖ) ile değerlendirilmiştir. Bulgular: Yatarak tedavi görmüş 102 alkol bağımlısı hastanın %61.8’i (n=63) alkol kullanımı depreşmiş olarak değerlendirilmiştir. Sosyodemografik değişkenler gruplar arasında fark göstermemiştir. MATT ve SCL-90 genel şiddet puanı gruplar arasında fark göstermemiş iken, aşerme puanı depreşen grupta yüksek bulunmuştur. Depreşen gruptakilerin 12 aylık takip süresince daha az poliklinik kontrolüne geldikleri, Ayaktan Tedavi Programı’na (ATP) daha az katıldıkları, kendilerini korumak amaçlı daha az sosyal çevre değişikliği yaptıkları ve aşerme için daha az ilaç kullandıkları bulunmuştur. Aşerme şiddeti ve takipte ATP’ye katılmama, alkol bağımlılarında depreşmeyi belirlemiştir. Sonuç: Aşerme şiddeti ve ATP’ye katılmama depreşme ile ilişkili temel etkenlerdir. Aşerme giderici ilaç kullanımı ile birlikte ATP’ye düzenli katılımın sağlanması, hastaların alkol aşermesini tanımalarına ve onunla başetmelerine yardımcı olabilir.

Factors related with relapse in male alcohol dependents: 12 months follow-up study

Objective: Aim of this study was to evaluate clinical variables related with relapse to alcohol abuse during 12 months follow-up after inpatient treatment in male alcohol dependents. Method: Participants were 156 consecutively admitted male alcohol dependents. Among these patients, 102 were available at the evaluation that took place one year after the inpatient treatment. Patients were investigated with the Symptom Check List (SCL-90) and Michigan Alcoholism Screening Test (MAST) at baseline and with the PENN Alcohol Craving Scale (PACS) one year later, at follow-up. Results: Among 102 alcohol dependent inpatients, 61.8% (n=63) were considered as relapsed to alcohol abuse. Sociodemographic variables did not differ between groups. Mean scores of MAST and global severity index of SCL-90 did not differ significantly between groups, whereas craving score was higher in the relapsed group. Also the relapsed group had less polyclinic control, less attendance to the Outpatient Treatment Program (OTP), less changes in social environment for self protection and less use of anti-craving medications during one year follow-up. Severity of craving and not attending OTP during follow-up period predicted relapse in alcohol dependents. Conclusions: Severity of craving and not attending OTP seems to be the main factors related with relapse. Together with using anti-craving medications, regular attendance to OTP may help patients to recognize and manage with alcohol craving.

Kaynakça

1. Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol 2001; 62:211–220.

2. Monahan S, Finney J. Explaining abstinence rates following treatment for alcohol abuse. A quantitative synthesis of patient, research design, and treatment effects. Addiction 1996; 91:787–805.

3. McLellan AT, Alterman AI, Metzger DS, Grissom G, Woody GE, Luborsky L, O’Brien CP. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. J Consult Clin Psychol 1994; 62:1141–1158.

4. Booth BM, Curran GM, Han X. Predictors of short-term course of drinking in untreated rural and urban at-risk drinkers: effects of gender, illegal drug use, and psychiatric comorbidity. J Stud Alcohol 2004; 65:63–73.

5. Bottlender M, Soyka M. Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment. Alcohol Alcohol 2004; 39:357-361.

6. Miller WR, Westerberg VS, Harris RJ, Tonigan JS. What predicts relapse? Prospective testing of antecedent models. Addiction 1996; 91:155–172.

7. Yates WR, Booth BM, Reed DA, Brown K, Masterson BJ. Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol 1993;54: 645–651.

8. Brown SA, Vik PW, Patterson TL, Grant I, Schuckit MA. Stress, vulnerability, and alcohol relapse. J Stud Alcohol 1995; 56:538–545.

9. Connors GJ, Maisto SA, Zywiak WH. Understanding relapse in the broader context of post-treatment functioning. Addiction 1996; 91:173–189.

10. Moss RH, Moss BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 2006; 101:212–222.

11. Monti PM, Abrams DB, Binkoff JA, Zwick WR., Liepman MR, Nirenberg TD, Rohsenow DJ. Communication skills training, communication skills training with family, and cognitive behavioral mood management training for alcoholics. J Stud Alcohol 1990; 51:263–270.

12. Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol 1997; 106:243–250.

13. O’Connor PG, Gottlieb LD, Kraus ML, Segal SR, Horwitz RI. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. J Gen Intern Med 1991; 6:312–316.

14. Singleton EG, Gorelick DA. Mechanisms of alcohol craving and their clinical implications. In: Galanter M (editor). Recent Developments in Alcoholism, Vol. 14: The consequences of alcoholism.. New York, NY: Plenum Press, 1998, 177–195.

15. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 2000; 20:149–171.

16. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 2001; 36:249–255.

17. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000; 20:173–189.

18. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 1999; 89:97–106.

19. Strowing AB. Relapse determinants reported by men treated for alcohol addiction: the prominence of depressed mood. J Subst Abuse Treat 2000; 19:469–474.

20. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello JR, Michael J. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 1998; 55:259–265.

21. Janowsky DS, Boone A, Morter S, Howe L. Personality and alcohol/substance-use disorder patient relapse and attendance at self-help group meetings. Alcohol Alcohol 1999; 34:359-369.

22. First MB, Spitzer RL, Gibbon M, Williams JBW. Stuructured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington D.C. and London: American Psychiatric Press, Inc, 1997.

23. Çorapçıoğlu A, Aydemir Ö, Yıldız M, Köroğlu E. DSM-IV Eksen I Bozuklukları (SCID-I) için Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Ankara. Hekimler Yayın Birliği, 1999.

24. Evren C, Cetin R, Durkaya M, Dalbudak E. Clinical Variables Related with Relapse during 6 Month Follow-up in Male Alcohol Dependents. Clinical Psychopharmacology Bulletin 2010; 20:14-22.

25. Derogatis LR. SCL-90: Administration, Scoring and Procedure Manual-II for the revised version, Tawson, Clinical Psychometric Research, 1983.

26. Dag I. Belirti tarama listesinin (SCL-90-R) üniversite öğrencileri için güvenirliği ve geçerliği. Türk Psikiyatri Dergisi 1991; 2:5-12.

27. Gibbs LE. Validity and reliability of the Michigan Alcoholism Screening Test: A review. Drug Alcohol Depend 1985; 12:279-285.

28. Coskunol H, Bagdiken I, Sorias S, Saygili R. Michigan Alkolizm Tarama Testinin Geçerliliği. Ege Tıp Dergisi 1995; 34:15-18.

29. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 1999; 23:1289-1295.

30. Evren C, Flannery B, Çelik R, Durkaya M, Dalbudak E. Penn Alkol Aşerme Ölçeği (PAAÖ) Türkçe Şeklinin Yatarak Tedavi Gören Erkek Alkol Bağımlısı Hastalarda Geçerliği ve Güvenirliği. Bağımlılık Dergisi 2008; 9:128-134.

31. Soyka M, Hasemann S, Scharfenberg CD, Löhnert B, Bottlender M. New possibilities in treatment and rehabilitation of alcoholdependent patients — a catamnestic study on the efficiency of outpatient treatment programmes demonstrated by a model procedure. Nervenarzt 2003; 74:226–234.

32. Addolorato G, Leggio L, Abenavoli L, Gasbarrini G. Alcoholism Treatment Study Group. Alcoholism Treatment Study Group. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 2005; 30:1209-1224.

33. Verheul R, Van Den Brink W, Geerlings P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 1999; 34:197–222.

34. Gordon SM, Sterling R, Siatkowski C, Raively K, Weinstein S, Hill PC. Inpatient desire to drink as a predictor of relapse to alcohol use following treatment. Am J Addict 2006; 15:242-245.

35. Evren C, Durkaya M, Çelik R, Dalbudak E, Çakmak D, Flannery B. Yatarak tedavi gören erkek alkol bağımlısı hastalarda alkol aşermesinin aleksitimi ve dissosiyasyon ile ilişkisi. Anadolu Psikiyatri Dergisi 2009; 10:165-173

36. Evren C, Çetin R, Durkaya M, Dalbudak E, Çakmak D. Yatarak Tedavi Gören Erkek Alkol Bağımlısı Hastalarda Alkol Aşermesinin Travma Sonrası Stres Bozukluğu ve Genel Psikopatolojinin Şiddeti ile İlişkisi. NöroPsikiyatri Arşivi 2009; 46:3-7

37. Larimer ME, Palmer RS, Marlatt GA. Relapse prevention. An overview of Marlatt’s cognitive-behavioral model. Alcohol Res Health 1999; 23:151-160.

38. Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 2009; 34:1198-1208.

39. Ornstein P, Cherepon JA. Demographic variables as predictors of alcoholism treatment outcome. J Stud Alcohol 1985; 46:425–432.

40. Jarvis TJ. Implications of gender for alcohol treatment research: a quantitative and qualitative review. Br J Addict 1992; 87:1249–1261.

41. Zywiak WH, Stout RL, Trefry WB, Glasser I, Connors GJ, Maisto SA, Westerberg VS. Alcohol relapse repetition, gender, and predictive validity. J Subst Abuse Treat 2006; 30:349-353.

42. Armor DJ, Meshkoff JE. Remission among treated and untreated alcoholics. Adv Subst Abuse 1983; 3:239–269.

43. Mundle G, Ackermann K, Günthner A, Munkes J, Mann K. Treatment outcome in alcoholism - a comparison of self-report and the biological markers carbohydrate-deficient transferrin and gamma-glutamyl transferase. Eur Addict Res 1999; 5:91-96.

44. Babor TF, Steinberg K, Anton R, Del Boca F. Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol 2000; 61:55-63.

45. Boening JAL, Lesch OM, Spanagl R, Wolfgramm J, Narita M, Sinclair D, Mason BJ, Wiesbeck GA. Pharmacological relapse prevention in alcohol dependence: From animal models to clinical trials. Alcohol Clin Exp Res 2001;25 (Suppl. 5):127 –131.

46. Soyka M, Chick J. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective. Am J Addict 2003; 12 (Suppl. 1):69-80.

47. Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999; 67:563-570.

Kaynak Göster

  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984

4.8b 3b

Sayıdaki Diğer Makaleler

Çocuk ve ergen psikiyatrisi polikliniğine başvuran hastalarda belirti ve tanı dağılımları

EVRİM AKTEPE, Kadir DEMİRCİ, Ali Metehan ÇALIŞKAN, YONCA SÖNMEZ

Antiepileptik barbeksaklon (maliasin®) bağımlılığı olan iki olgu

Esra SEZGİN, Cüneyt EVREN, Özgül Gülömür ÇINAR, SUAT KÜÇÜKGÖNCÜ, Mübrra Kılıç BAYRAM

Yeme bozuklukları ve duygusal istismar: Olgu sunumu

Aylin AĞIRMAN, Fulya MANER

Korpus kallosum atrofisi ve psikoz: Bir olgu sunumu

YASEMİN GÖRGÜLÜ, Serap Çakıcı ALPARSLAN, Niyazi UYGUR

Erkek alkol bağımlılarında depreşme ile ilişkili etkenler: 12 aylık takip çalışması

Cüneyt EVREN, Mine DURKAYA, ERCAN DALBUDAK, Selime ÇELİK, Rabia ÇETİN, Duran ÇAKMAK

Bipolar I bozukluk ve antidepresana bağlı mani/hipomani klinik özelliklerinin karşılaştırılması

Nesrin TOMRUK, Ömer SAATÇİOĞLU, BURCU RAHŞAN ERİM, Nihat ALPAY

Psikiyatri konsültasyonu istenen geriatrik hastaların özellikleri: Geriye dönük karşılaştırmalı bir çalışma

ALİ KEYVAN, VOLKAN TOPÇUOĞLU, Aylan Gımzal GÖNENTÜRK, M. Kemal KUŞÇU, İ. Çağrı YAZGAN, Nurhan FISTIKÇI

Relationship between dissociative experiences, abnormal sleep experiences, and sleep quality in undergraduate students

SUAT KÜÇÜKGÖNCÜ, Evin AKTAR, Ebru ERGİNBAŞ, E. Emrem BEŞTEPE, Celal ÇALIKUŞU, Fulya ALGIN, Şahap ERKOÇ

Comparing the effectiveness of mood stabilizers and antidepressants for bipolar depression treatment: A retrospective chart review

Kürşat ALTINBAŞ, Timuçin E. ORAL, Danny SMITH, Nickholas CRADDOCK

Olfaktör referans sendromu: Olgu sunumu

Emine Ebru AKSU, Haluk AKSU, Abdülkadir TABO, Ömer SAATÇİOĞLU